Search results

Discover how eCOA software enhances clinical trials with real-time data capture, faster, scalable builds, and a modern, consumer-grade experience. Learn why cloud-based solutions improve efficiency, compliance, and patient engagement.

Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.

Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.

Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.

With MarketsandMarkets projecting the global electronic Clinical Outcome Assessments (eCOA) solutions market to grow at compound annual growth rate (CAGR) of 16.1% each year until 2030, it’s clear the eCOA has made its impact within the clinical research landscape. Yet despite growing adoption, electronic Clinical Outcome Assessments (eCOA) are still surrounded by misconceptions that hinder their full potential. From concerns about patient usability to assumptions about cost and implementation timelines, these myths can create hesitation among sponsors and research teams alike.Thus, we’re here to cut through the noise and set the record straight with a summary of a recent webinar featuring speakers from Transcelerate and Medable.

Medable is an end-to-end, cloud-based platform with a scalable suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient workflows and patient-focused data collection. Click to learn more.

With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.

Gain a quick overview of what top trends and topics dominated DIA 2023.

This blog describes software as a service and how the life sciences industry uses it today.

Discover how eCOA software is reshaping modern clinical trials by enabling decentralized designs, enhancing patient adherence, and optimizing data collection through real-time digital tools. Learn how cloud-based solutions and AI are driving the next evolution in clinical research.

For years, sponsors and CROs have lamented the lack of control and transparency, particularly with technology, during study launches. See how Medable Studio solves these issues, and others around assessments, instruments, and translations.

Discover a unified digital platform for clinical trials with best-in-class decentralized and eCOA software. Streamline data collection, scale globally, and deliver smarter, faster results.

Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.

See what happened at this year's annual J.P.M. week with this blog.

Your questions about decentralized clinical trials answered. Read to learn more about Medable and its cloud based, SaaS tools, from total consent, ecoas, and more

A summary of JPM2024 news, trends, and highlights that made waves during this year’s conference.

Uncover some of the more common challenges and preferences of patients and their caregivers.

See why many of the top pharma are focused on building the "next model" of clinical trial conduct using foundational platforms.

The clinical trial landscape is experiencing a data revolution. According to the Tufts 2020 report, over two-thirds of sponsors are now using or piloting at least four different data sources in their clinical trials, with almost 14% using six. This uptick comes from a diverse pool of data sources, such as eConsent (electronic informed consent) data, eCOA data, mHealth data, smartphone data, eSource data, etc., and reflects the industry's move towards more comprehensive and nuanced data collection.

Learn how Medable's eCOA (electronic clinical outcome assessment) solution was able to deliver >90% adherence and scalability for a top pharmaceutical weight management clinical trial.

Contact Medable for a demo and to learn more about DCT certification, careers, and support. Medable, per Everest Group Peak matrix, is the top decentralized clinical trial company.

The rise of SaaS has transformed industries, including life sciences, by enabling new possibilities. For instance, Salesforce revolutionized how organizations managed their customers and future clients with its cloud-based software, enhancing accessibility and collaboration. Similarly, Canva made graphic design tools accessible to all, empowering professionals and casual users alike.

Electronic clinical outcome assessments (eCOAs) have revolutionized clinical trials, offering significant advantages over traditional paper-based methods. By enhancing data quality, streamlining data collection, improving patient engagement, and enabling real-time data access, eCOAs have become indispensable tools in modern clinical research. However, successful eCOA implementation requires careful planning, meticulous execution, and a deep understanding of the regulatory landscape. This comprehensive guide provides a detailed roadmap for implementing eCOAs effectively, covering key aspects from study design to future trends.

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).

A top 10 pharmaceutical company looked to Medable to streamline participant burden and enhance site and team experience in oncology trials, while establishing a scalable template for future trials in oncology and other areas.

Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.

See how customers have had success with Medable, our trial platform, and our teams.

Learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.

A top-3 contract research organization (CRO) and a top-10 pharmaceutical company partnered with Medable to help accelerate the speed, scale, and standardization of their eCOA trials.The two organizations had been hampered by lengthy configuration timelines, inconsistent designs across studies, and siloed processes between sponsors and their CRO partners.By centralizing the sponsor’s preferred instruments and configurations into a reusable digital library, Medable enabled the CRO to rapidly accelerate its portfolio development and initiate new studies without starting them “from scratch.”‍

Join Medable's Mohammed Ali, Chief Domain Expert and Shubha Govil, SVP of Product Management,Platform to hear how top pharma teams have adopted digital technology across a platform to reduce costs and accelerate time to market.

Medable worked with a top 5 pharma company to increase the safety of patients as anti-cancer treatments may cause pulmonary toxicity, ranging from asymptomatic radiological changes to respiratory failure, and is considered a common side effect.

Learn how we can help you navigate the complexities of clinical operations so that you can meet your study's milestones faster and easier.

In this webinar, learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.

A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. Recognizing Japan’s distinct regulatory, cultural, and logistical landscape, the company partnered with Medable to develop an initiative to enhance the region’s patient and site experience.

See how Medable was able to increase study startup speed for one customer by 50%.

See how Medable helped one customer achieve their fastest enrollment ever.

The partnership between Medable, U.S. Renal Care, and the top ten pharmaceutical sponsor exemplifies the transformative power of Medable’s Total Consent solution in clinical trials. By overcoming common misconceptions around participant age, cost, and complexity, Medable’s platform proved to be a flexible, fast, and efficient solution for the elderly renal care population. U.S. Renal Care sought to use Medable’s Total Consent (Medable’s eConsent solution) for an investigator-initiated trial. The phase 4 trial, which was funded by a top 10 pharmaceutical company, sought to enroll elderly participants suffering from Anemia ESKD (End Stage Kidney Disease) across 476 site users. The trial would be managed by three central principal investigators (PIs).

A top, global clinical research organization (CRO) partnered with Medable to transform its approach to clinical trial building. Recognizing the inefficiencies in traditional build processes that often “take weeks,” the client leveraged Medable’s Studio platform with its latest AI capabilities to dramatically accelerate timelines, enhance transparency, and improve quality. ‍‍

Colin Miller, Co-Founder and CEO at The Bracken Group sits down with Medable to talk about the coming revolutionb of digital biomarkers and how they'll further clinical research.